Literature DB >> 9579837

Late effects of treatment for early-stage Hodgkin's disease.

J D Brierley1, A J Rathmell, M K Gospodarowicz, S B Sutcliffe, A Munro, R Tsang, M Pintilie.   

Abstract

A comprehensive survey of late effects (physical, social and reproductive) following treatment at a single institution for early stage Hodgkin's disease (HD) was performed. A total of 611 patients with stage I and II HD treated between 1973 and 1984 were reviewed; 460 were alive and were mailed a self-reported questionnaire. A total of 363 (79%) replies were received. Twenty patients died of second malignancy, 14 of heart disease and nine from respiratory disease. There were 37 cases of second malignancy [relative risk (RR) 2.2, absolute excess risk (AR) 35.8]. The 15-year incidence of heart disease was 11% and there were nine myocardial infarction deaths (RR 1.55, AR 5.4). Twenty-eight (8%) respondents stated that their career had been greatly interfered with, 53 (14.5%) perceived financial loss. Sexual activity was disrupted in 25.8%. In total, 56 men had fathered 112 pregnancies. Of 171 women, 40.3% became pregnant, resulting in 92 live births. A total of 43 men and 16 women had sought medical advice with regard to infertility.

Entities:  

Mesh:

Year:  1998        PMID: 9579837      PMCID: PMC2150150          DOI: 10.1038/bjc.1998.217

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

Review 1.  Radiation therapy in the management of Hodgkin's disease.

Authors:  R T Hoppe
Journal:  Semin Oncol       Date:  1990-12       Impact factor: 4.929

2.  Thoracic irradiation in Hodgkin's disease: disease control and long-term complications.

Authors:  N J Tarbell; L Thompson; P Mauch
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-02       Impact factor: 7.038

3.  Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.

Authors:  P M Mauch; L A Kalish; K C Marcus; L N Shulman; E Krill; N J Tarbell; B Silver; H Weinstein; S Come; G P Canellos; C N Coleman
Journal:  Cancer J Sci Am       Date:  1995 May-Jun

4.  Risk of second cancers after treatment for Hodgkin's disease.

Authors:  M A Tucker; C N Coleman; R S Cox; A Varghese; S A Rosenberg
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

5.  The incidence of herpes zoster in patients with Hodgkin's disease. An analysis of prognostic factors.

Authors:  V F Guinee; J J Guido; K A Pfalzgraf; G G Giacco; C Lagarde; M Durand; J W van der Velden; B Löwenberg; B Jereb; S Bretsky
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

6.  Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.

Authors:  S L Hancock; R T Hoppe; S J Horning; S A Rosenberg
Journal:  Ann Intern Med       Date:  1988-08-01       Impact factor: 25.391

7.  Breast cancer and other second neoplasms after childhood Hodgkin's disease.

Authors:  S Bhatia; L L Robison; O Oberlin; M Greenberg; G Bunin; F Fossati-Bellani; A T Meadows
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

8.  Psychosocial problems among survivors of Hodgkin's disease.

Authors:  P Fobair; R T Hoppe; J Bloom; R Cox; A Varghese; D Spiegel
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

9.  Second acute leukemia and other malignancies following treatment for Hodgkin's disease.

Authors:  P Valagussa; A Santoro; F Fossati-Bellani; A Banfi; G Bonadonna
Journal:  J Clin Oncol       Date:  1986-06       Impact factor: 44.544

10.  Male gonadal dysfunction in Hodgkin's disease. A prospective study.

Authors:  R M Chapman; S B Sutcliffe; J S Malpas
Journal:  JAMA       Date:  1981-04-03       Impact factor: 56.272

View more
  6 in total

Review 1.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

2.  Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.

Authors:  I Glimelius; S Ekberg; J Linderoth; M Jerkeman; E T Chang; M Neovius; K E Smedby
Journal:  J Cancer Surviv       Date:  2015-02-18       Impact factor: 4.442

3.  Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.

Authors:  A Vacca; D Ribatti; L Ruco; F Giacchetta; B Nico; F Quondamatteo; R Ria; M Iurlaro; F Dammacco
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

4.  Long-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis.

Authors:  Devon J Boyne; Alexis T Mickle; Darren R Brenner; Christine M Friedenreich; Winson Y Cheung; Karen L Tang; Todd A Wilson; Diane L Lorenzetti; Matthew T James; Paul E Ronksley; Doreen M Rabi
Journal:  Cancer Med       Date:  2018-08-15       Impact factor: 4.452

5.  Attitudes toward fertility and fertility preservation in women with glioma.

Authors:  Rachel K Stiner; Jennifer L Clarke; Nikita Sinha; Jessica Chan; Joseph M Letourneau; Erin E Niemasik; Jane E Rabbitt; Susan M Chang; Nicholas A Butowski; Michael D Prados; Mitchell P Rosen
Journal:  Neurooncol Pract       Date:  2018-09-26

6.  Hodgkin's disease and birth outcome: a Danish nationwide cohort study.

Authors:  V Langagergaard; E Horvath-Puho; M Nørgaard; B Nørgård; H T Sørensen
Journal:  Br J Cancer       Date:  2007-12-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.